GlassScriptPhysician profile
Amr El-Khashab
NPI 1336566025
$28,843.64
in general payments reported to CMS, 2019-2025
22 companies · $2,014 in 2025
The $2,014 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,990 · 2020: $1,680 · 2021: $2,388 · 2022: $4,972 · 2023: $12K · 2024: $1,058 · 2025: $2,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,750 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,675 · Travel and Lodging: $3,146 · Food and Beverage: $1,242 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,750.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,675.00 |
| Travel and Lodging | $3,145.98 |
| Food and Beverage | $1,241.52 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nvision Biomedical Technologies, INC. | $6,980.78 | 2022-2024 | Foot and Ankle, Trigon |
| Kerecis Limited | $6,035.08 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| In2bones USA, LLC | $5,743.62 | 2019-2022 | |
| Stryker Corporation | $4,277.08 | 2019-2025 | Augment Injectable, Citrefix |
| Vilex LLC | $1,859.70 | 2025 | Hintermann |
| Paragon 28, INC. | $1,499.16 | 2021-2023 | Silverback |
| Linvatec Corporation | $1,366.98 | 2023-2024 | Pit'Stop, Biobrace 23mm, Hercules |
| Wright Medical Technology, INC. | $473.19 | 2019 | |
| Sanara Medtech INC. | $146.61 | 2021 | |
| Amgen INC. | $82.56 | 2024-2025 | Krystexxa |
| Bioventus LLC | $58.92 | 2024 | Bonescalpel & Sonicone (O.R.), Gelsyn-3 |
| Trilliant Surgical LLC. | $53.87 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.01 | 2023 | Jublia |
| Smith+Nephew, INC. | $34.84 | 2019-2024 | Collagenase Santyl |
| Theramicro, INC. | $33.45 | 2025 | Allostat Gfx, Tekbrace Solo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $31.47 | 2025 | |
| Biotissue Holdings INC. | $26.14 | 2022 | |
| Medinc of Texas | $24.17 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $20.82 | 2022 | |
| Paratek Pharmaceuticals, INC. | $20.10 | 2024 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $16.84 | 2022 | |
| Ets Wound Care LLC | $7.25 | 2024 | Mirragen Advanced Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amr El-Khashab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.